secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2022-04-27T23:59:59+00:00
Accession:  0001558370-22-006090
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Q1 net loss $6.67B on $6.6B goodwill impairment; cuts 2022 guidance
---------------------------------------------------------------------------

- Q1 revenue $565.4M (+25% YoY); net loss $6.67B due to $6.6B non-cash goodwill impairment ($41.11/sh).
- Adjusted EBITDA $54.5M (-4% YoY); net loss per share $41.58 vs. $1.31 a year ago.
- FY 2022 guidance revised: revenue $2.4-2.5B, adj. EBITDA $240-265M, net loss per share ($43.50)-($43.00).
- D2C mental health hit by higher ad costs with lower yield; chronic condition sales cycles elongated.
- Primary360 and stepped-care chronic programs launched on multiple new clients in Q1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000155837022006090/0001558370-22-006090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000155837022006090/tdoc-20220427x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-006090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer